Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery
Permalink: https://cordis.europa.eu/project/id/732386/news
© European Union, 2022